Importer of Controlled Substances; Notice of Registration; Noramco, Inc., 35052-35053 [2013-13869]
Download as PDF
<![CDATA[
35052
Federal Register / Vol. 78, No. 112 / Tuesday, June 11, 2013 / Notices
Carsem filed a combined petition for
panel rehearing and for rehearing en
banc. The Court denied Carsem’s
petition on December 7, 2012, and
issued its mandate on December 19,
2012, returning jurisdiction to the
Commission.
On January 14, 2013, the Commission
issued an Order (‘‘Commission’s
Order’’) requesting the parties to the
investigation to submit initial comments
regarding what further proceedings
must be conducted to comply with the
Federal Circuit’s August 22, 2012,
judgment in Amkor Technology. The
parties filed their initial and responsive
submissions.
Having examined the record in this
investigation, including the parties’
submissions filed in response to the
Commission’s Order, the Commission
has determined to request briefing from
the parties on only the following issues,
with reference to the applicable law and
the evidentiary record:
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Whether there is any intervening legal
precedent since the issuance of the 2004
Final ID that precludes or warrants the ALJ’s
determination that Amkor satisfied the
economic prong of the domestic industry
requirement under section 337(a)(3)(A), and
did not satisfy the economic prong under
section 337(a)(3)(B). See 19 U.S.C.
1337(a)(3)(A) and (B).
In connection with the final
disposition of this investigation, the
Commission may (1) issue an order that
could result in the exclusion of the
subject articles from entry into the
United States, and/or (2) issue one or
more cease and desist orders that could
result in the respondents being required
to cease and desist from engaging in
unfair acts in the importation and sale
of such articles. Accordingly, the
Commission is interested in receiving
written submissions that address the
form of remedy, if any, that should be
ordered. If a party seeks exclusion of an
article from entry into the United States
for purposes other than entry for
consumption, the party should so
indicate and provide information
establishing that activities involving
other types of entry either are adversely
affecting it or are likely to do so. For
background, see Certain Devices for
Connecting Computers via Telephone
Lines, Inv. No. 337–TA–360, USITC
Pub. No. 2843 Comm’n Op. (Dec. 1994).
If the Commission contemplates some
form of remedy, it must consider the
effects of that remedy upon the public
interest. The factors the Commission
will consider include the effect that an
exclusion order and/or cease and desist
orders would have on (1) the public
health and welfare, (2) competitive
conditions in the U.S. economy, (3) U.S.
VerDate Mar<15>2010
15:13 Jun 10, 2013
Jkt 229001
production of articles that are like or
directly competitive with those that are
subject to investigation, and (4) U.S.
consumers. The Commission is
therefore interested in receiving written
submissions that address the
aforementioned public interest factors
in the context of this investigation. The
Commission also requests briefing as to
the following question:
Whether for purposes of our public interest
analysis, there are products comparable to
the subject articles that are noninfringing
products in the U.S. market.
If the Commission orders some form
of remedy, the President has 60 days to
approve or disapprove the
Commission’s action. During this
period, the subject articles would be
entitled to enter the United States under
bond, in an amount determined by the
Commission and prescribed by the
Secretary of the Treasury. The
Commission is therefore interested in
receiving submissions concerning the
amount of the bond that should be
imposed.
Written Submissions: The parties to
the investigation are requested to file
written submissions on the issues
specified in this Notice. The
submissions should be concise and
thoroughly referenced to the record in
this investigation. Parties to the
investigation, interested government
agencies, and any other interested
persons are encouraged to file written
submissions on the issues of remedy,
the public interest, and bonding. Such
submissions should address the
recommended determination by the ALJ
on remedy and bonding issued on
November 18, 2004. Complainant and
the Commission investigative attorney
are also requested to submit proposed
remedial orders for the Commission’s
consideration. Complainant is further
requested to provide the expiration
dates of the asserted patents at issue in
this investigation and state the HTSUS
number under which the accused
articles are imported. The written
submissions and proposed remedial
orders must be filed no later than the
close of business on Wednesday, June
19, 2013. Reply submissions must be
filed no later than the close of business
on Wednesday, June 26, 2013. No
further submissions on these issues will
be permitted unless otherwise ordered
by the Commission.
Persons filing written submissions
must file the original document
electronically on or before the deadlines
stated above and submit 8 true paper
copies to the Office of the Secretary by
noon the next day pursuant to section
210.4(f) of the Commission’s Rules of
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Practice and Procedure (19 CFR
210.4(f)). Submissions should refer to
the investigation number (‘‘Inv. No.
337–TA–501’’) in a prominent place on
the cover page and/or the first page. (See
Handbook for Electronic Filing
Procedures, https://www.usitc.gov/
secretary/fed_reg_notices/rules/
handbook_on_electronic_filing.pdf).
Persons with questions regarding filing
should contact the Secretary (202–205–
2000).
Any person desiring to submit a
document to the Commission in
confidence must request confidential
treatment. All such requests should be
directed to the Secretary to the
Commission and must include a full
statement of the reasons why the
Commission should grant such
treatment. See 19 CFR 201.6. Documents
for which confidential treatment by the
Commission is properly sought will be
treated accordingly. A redacted nonconfidential version of the document
must also be filed simultaneously with
the any confidential filing. All nonconfidential written submissions will be
available for public inspection at the
Office of the Secretary and on EDIS.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in
sections 210.42–.46 of the Commission’s
Rules of Practice and Procedure (19 CFR
210.42–.46).
Issued: June 5, 2013.
By order of the Commission.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2013–13747 Filed 6–10–13; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Noramco, Inc.
By Notice dated March 12, 2013, and
published in the Federal Register on
March 20, 2013, 78 FR 17230, Noramco,
Inc., 1440 Olympic Drive, Athens,
Georgia 30601, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the basic classes of
controlled substances:
Drug
Phenylacetone (8501) ..................
Thebaine (9333) ...........................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
E:\FR\FM\11JNN1.SGM
11JNN1
Schedule
II
II
II
II
Federal Register / Vol. 78, No. 112 / Tuesday, June 11, 2013 / Notices
The company plans to import
Thebaine (9333) analytical reference
standards for distribution to its
customers. The company plans to
import an intermediate form of
Tapentadol (9780) to bulk manufacture
Tapentadol for distribution to its
customers. The company plans to
import Phenylacetone (8501) and Poppy
Straw Concentrate (9670) to
manufacture other controlled
substances.
The company has withdrawn its
request to import the drug code
Noroxymorphone (9668).
Comments and requests for hearings
on applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007).
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a), and
determined that the registration of
Noramco, Inc., to import the basic
classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Noramco, Inc., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR § 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
wreier-aviles on DSK5TPTVN1PROD with NOTICES
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Evaluation
of the Army Unemployment
Compensation for Ex-Servicemembers
(UCX) Claimants Initiative
Notice.
SUMMARY: The Department of Labor
(DOL), as part of its continuing effort to
reduce paperwork and respondent
VerDate Mar<15>2010
15:13 Jun 10, 2013
Jkt 229001
Written comments must be
submitted to the office listed in the
addressee section below on or before
August 12, 2013.
ADDRESSES: You may submit comments
by either one of the following methods:
Email: javar.janet.o@dol.gov; Mail or
Courier: Janet Javar, Chief Evaluation
Office, U.S. Department of Labor, Room
S–2218, 200 Constitution Avenue NW.,
Washington, DC 20210. Instructions:
Please submit one copy of your
comments by only one method. All
submissions received must include the
agency name and OMB Control Number
identified above for this information
collection. Because we continue to
experience delays in receiving mail in
the Washington, DC area, commenters
are strongly encouraged to transmit their
comments electronically via email or to
submit them by mail early. Comments,
including any personal information
provided, become a matter of public
record. They will also be summarized
and/or included in the request for OMB
approval of the information collection
request.
DATES:
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2013–13869 Filed 6–10–13; 8:45 am]
ACTION:
burden, conducts a preclearance
consultation program to provide the
general public and Federal agencies
with an opportunity to comment on
proposed and/or continuing collections
of information in accordance with the
Paperwork Reduction Act of 1995
(PRA95). This program helps to ensure
that required data can be provided in
the desired format, reporting burden
(time and financial resources) is
minimized, collection instruments are
clearly understood, and the impact of
collection requirements on respondents
can be properly assessed.
A copy of the proposed ICR can be
obtained by contacting the office listed
below in the addressee section of this
notice.
Janet Javar by telephone at 202–693–
5954 (this is not a toll-free number) or
by email at javar.janet.o@dol.gov.
SUPPLEMENTARY INFORMATION:
I. Background: The Army
Unemployment Compensation for ExService Members (UCX) Claimants’
Initiative, funded by the U.S.
Department of Labor, Employment and
Training Administration (ETA),
provides grants to four states to improve
strategies for providing reemployment
services to Army UCX claimants and for
leveraging assets and sharing data across
partners. The major goals of the
initiative are to create a strong
collaborative partnership among the
Unemployment Insurance (UI) system,
the public workforce system, and the
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
35053
three components of the Army (active,
National Guard, and Reserve) that will
support the rapid reemployment of UCX
claimants; improve the sharing of UCX
data that will lead to improved outreach
and better understanding of UCX
claimants and their service delivery
needs; and increase outreach, exposure
to jobs, and reemployment strategies for
UCX claimants that fully leverage
existing resources with new and
innovative service delivery strategies.
The period of performance for the grants
is from July 1, 2012, to June 30, 2014.
The purpose of the evaluation, funded
by the Chief Evaluation Office, is to
determine the extent to which the
initiative’s goals were achieved by each
of the four grantee states. The evaluation
will examine the services received by
UCX claimants and how claimants’
employment outcomes changed over the
course of the grant period.
Policymakers, program administrators,
and service providers will gain
information about the relative
effectiveness of various strategies
developed by states, ease of
implementation, and suggestions for
replication.
This package requests clearance for
semi-structured discussions that will
take place during a single round of twoday visits to each of the sites in the
winter of 2013–2014. The site visits will
involve an array of individuals that
varies by state based on the projects that
each state has decided to implement.
Conversations will take place with
grantee leaders, staff of an American Job
Center, and representatives of the UI
system in each state. Other discussants
will include a suitable combination of
representatives of the Army and other
participants in the initiative. The site
visit will facilitate an assessment of the
progress of these efforts, information
gathering, and potential for the delivery
of additional in-person technical
assistance.
II. Desired Focus of Comments:
Currently, the Department of Labor is
soliciting comments concerning the
above data collection for Evaluation of
the Army UCX Claimants Initiative.
Comments are requested to:
* Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
* Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 78, Number 112 (Tuesday, June 11, 2013)]
[Notices]
[Pages 35052-35053]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13869]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration;
Noramco, Inc.
By Notice dated March 12, 2013, and published in the Federal
Register on March 20, 2013, 78 FR 17230, Noramco, Inc., 1440 Olympic
Drive, Athens, Georgia 30601, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Thebaine (9333)............................ II
Poppy Straw Concentrate (9670)............. II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
[[Page 35053]]
The company plans to import Thebaine (9333) analytical reference
standards for distribution to its customers. The company plans to
import an intermediate form of Tapentadol (9780) to bulk manufacture
Tapentadol for distribution to its customers. The company plans to
import Phenylacetone (8501) and Poppy Straw Concentrate (9670) to
manufacture other controlled substances.
The company has withdrawn its request to import the drug code
Noroxymorphone (9668).
Comments and requests for hearings on applications to import
narcotic raw material are not appropriate. 72 FR 3417 (2007).
DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and
determined that the registration of Noramco, Inc., to import the basic
classes of controlled substances is consistent with the public
interest, and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971, at this
time. DEA has investigated Noramco, Inc., to ensure that the company's
registration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR
Sec. 1301.34, the above named company is granted registration as an
importer of the basic classes of controlled substances listed.
Dated: May 24, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-13869 Filed 6-10-13; 8:45 am]
BILLING CODE 4410-09-P
